Processa Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Processa Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2012 to Q2 2024.
  • Processa Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$3.01M, a 15.2% decline year-over-year.
  • Processa Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.2M, a 60.2% increase year-over-year.
  • Processa Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$11.1M, a 59.4% increase from 2022.
  • Processa Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$27.4M, a 140% decline from 2021.
  • Processa Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$11.4M, a 20.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$10.2M -$3.01M -$398K -15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$9.83M -$2.73M +$1.3M +32.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$11.1M -$2.4M +$10.6M +81.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$21.7M -$2.08M +$3.94M +65.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$25.7M -$2.61M +$2.55M +49.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$28.2M -$4.02M -$795K -24.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 -$27.4M -$13M -$9.83M -309% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$17.6M -$6.02M -$3.03M -102% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$14.6M -$5.16M -$2.01M -63.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$12.6M -$3.23M -$1.13M -53.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$11.4M -$3.18M +$6.55M +67.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$18M -$2.99M +$84.1K +2.74% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$18.1M -$3.16M -$2.42M -330% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-08
Q1 2021 -$15.6M -$2.1M -$1.23M -140% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-08
Q4 2020 -$14.4M -$9.73M -$8.96M -1157% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$5.45M -$3.07M -$2.21M -256% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$3.25M -$733K +$236K +24.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$3.48M -$874K -$124K -16.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$3.36M -$774K -$165K -27.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$3.19M -$864K -$10.7K -1.26% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$3.18M -$969K +$237K +19.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$3.42M -$751K +$346K +31.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$3.77M -$609K +$24.7K +3.9% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-06
Q3 2018 -$3.79M -$853K -$141K -19.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$3.65M -$1.21M -$928K -333% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$2.72M -$1.1M -$864K -372% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 -$1.86M -$634K -$400K -170% Oct 1, 2017 Dec 31, 2017 10-K 2018-04-16
Q3 2017 -$1.46M -$712K +$116K +14% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.57M -$278K +$296K +51.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$1.87M -$232K +$48.5K +17.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$1.92M -$234K +$128K +35.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 -$2.05M -$827K -$532K -180% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 -$1.51M -$574K +$1.48M +72% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 -$2.99M -$281K +$364K +56.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 -$3.35M -$363K +$1.18M +76.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-09-25
Q3 2015 -$4.53M -$296K +$496K +62.7% Jul 1, 2015 Sep 30, 2015 10-Q 2017-09-08
Q2 2015 -$5.03M -$2.05M -$1.2M -141% Apr 1, 2015 Jun 30, 2015 10-Q 2017-08-30
Q1 2015 -$3.83M -$645K +$700K +52% Jan 1, 2015 Mar 31, 2015 10-Q 2017-08-07
Q4 2014 -$4.53M -$1.54M -$732K -90.7% Oct 1, 2014 Dec 31, 2014 10-K 2017-06-19
Q3 2014 -$3.79M -$792K -$73.1K -10.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-01
Q2 2014 -$3.72M -$851K -$125K -17.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$3.6M -$1.34M -$528K -64.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$3.07M -$807K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-14
Q3 2013 -$719K -$117K -19.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$727K -$251K -52.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 -$816K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q3 2012 -$602K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$475K Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.